✦ LIBER ✦

Drug cost avoidance resulting from cancer clinical trials

✍ Scribed by Correne Bredin; Misha Eliasziw; Rachel Syme

Book ID: 116350939
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 231 KB
Volume: 31
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2010.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress resulting from clinical trials:

Progress resulting from clinical trials: Solid tumors in childhood cancer

✍ John N. Lukens 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

969: Avoided cost in chemotherapy drugs

969: Avoided cost in chemotherapy drugs attributable to patients inclusion in clinical trials

✍ Sanchez, M.; Chacon, J.I.; Rubio, A.R.; Gonzalez, A.; Cruz, M.A.; Moya, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Drug costs and out-of-pocket spending in

Drug costs and out-of-pocket spending in cancer clinical trials

✍ Meredith L. Kilgore; Dana P. Goldman 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Cost-effectiveness and lung cancer clini

Cost-effectiveness and lung cancer clinical trials

✍ Wei Du; Jaxk H. Reeves; Shirish Gadgeel; Judith Abrams; William P. Peters 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

## Abstract ## BACKGROUND Lung cancer is the leading cause of cancer death in the U.S., with an estimated annual economic burden of $5 billion. Clinical trials offer innovative therapeutic options with potentially better outcomes, but their effects on health care costs are disputed. ## METHODS T

Generalizability of cancer clinical tria

Generalizability of cancer clinical trial results

✍ Noel S. Weiss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

W2: ESTIMATING DRUG EFFECTS: FROM CLINIC

W2: ESTIMATING DRUG EFFECTS: FROM CLINICAL TRIAL RESULTS TO ACTUAL PRACTICE

✍ JJ Caro; K Migliaccio-Walle; I Thizon de Gaulle; A Coniglio 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB